Google Alert - pharmaceutical news

News 7 new results for pharmaceutical news

Fosun Pharmaceutical Shares Fall 8% on Hong Kong Debut Wall Street Journal HONG KONG—Drug maker Shanghai Fosun Pharmaceutical (Group) Co., which raised $512 million in the first major initial public offering in Hong Kong in months, saw its shares fall 8% on their debut Tuesday, signaling that demand for new share sales has ... See all stories on this topic »

Glenmark Q2 net up nearly three fold at Rs 156.75 cr Zee News New Delhi: Glenmark Pharmaceuticals on Tuesday said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended September 30, 2012, mainly on account of robust sales across all segments. The company had posted a net ... See all stories on this topic » Zee News

Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results ... Sacramento Bee MONTREAL, Oct. 30, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has decided to reschedule its webcast and conference call to discuss financial results for the 2012 third quarter ... See all stories on this topic »

Ohio to Get $1.4M in Pharmaceutical Settlement Pharmaceutical Processing The U.S. Justice Department said Thursday that Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted. The Justice Department says the three ... See all stories on this topic »

Watson Pharma sells Rugby OTC product trademark & assets for $117 mn to ... pharmabiz.com Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, has sold its Rugby over-the-counter (OTC) pharmaceutical products and trademarks to The Harvard Drug Group, LLC, a leading distributor and provider of private label OTCs and ... See all stories on this topic »

Cardinal Health quarterly profits rise, reaffirms outlook Reuters Revenue dipped 3 percent to $25.9 billion in the quarter, with revenue from its pharmaceutical segment declining 4 percent to $23.5 billion and revenue from its medical segment rising 1 percent to $2.4 billion. Cardinal blamed slow growth in its ... See all stories on this topic »

Astex Pharmaceuticals gives £5m boost to Newcastle University nebusiness.co.uk Newcastle University has cemented its reputation as a world leader in the fight against the illness as it has signed a £5m partnership with an international pharmaceutical company to develop new cancer drugs. Astex Pharmaceuticals – a global leader in ... See all stories on this topic »

---

Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.